Professur für Translationale Frauenheilkunde und Geburtshilfe

Address:
Universitätsstraße 21/23
91054 Erlangen


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 15 Go to next page Go to last page

Mavratzas, A., Baek, S., Gerber, B., Schmidt, M., Moebus, ., Foerster, F.,... Marine, F. (2019). Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study. BREAST , 45, 22-28. https://dx.doi.org/10.1016/j.breast.2019.02.002
Noske, A., Möbus, V., Weber, K., Schmatloch, S., Weichert, W., Köhne, C.H.,... Denkert, C. (2019). Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node–positive study. European journal of cancer, 114, 76-88. https://dx.doi.org/10.1016/j.ejca.2019.04.010
Turner, N.C., Telli, M.L., Rugo, H.S., Mailliez, A., Ettl, J., Grischke, E.-M.,... Robson, M.E. (2019). A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO). Clinical Cancer Research, 25(9), 2717-2724. https://dx.doi.org/10.1158/1078-0432.CCR-18-1891
Ferreira, M.A., Gamazon, E.R., Al-Ejeh, F., Aittomaki, K., Andrulis, I.L., Anton-Culver, H.,... Yip, D. (2019). Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nature Communications, 10. https://dx.doi.org/10.1038/s41467-018-08053-5
Deniz, M., Degregorio, A., Degregorio, N., Bekes, I., Widschwendter, P., Schochter, F.,... Friedl, T.W.P. (2019). Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study. BREAST , 44, 81-89. https://dx.doi.org/10.1016/j.breast.2018.12.008
Wunderle, M., Pretscher, J., Brucker, S.Y., Volz, B., Hartmann, A., Fiessler, C.,... Rauh, C. (2019). Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment, 174(2), 453-461. https://dx.doi.org/10.1007/s10549-018-05115-6
Escala-Garcia, M., Guo, Q., Doerk, T., Canisius, S., Keeman, R., Dennis, J.,... Schmidt, M.K. (2019). Genome-wide association study of germline variants and breast cancer-specific mortality. British Journal of Cancer, 120(6), 647-657. https://dx.doi.org/10.1038/s41416-019-0393-x
Hartkopf, A.D., Mueller, V., Woeckel, A., Lux, M.P., Janni, W., Nabieva, N.,... Tesch, H. (2019). Update Breast Cancer 2019 Part 1-Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer. Geburtshilfe und Frauenheilkunde, 79(3), 256-267. https://dx.doi.org/10.1055/a-0842-6614
Janni, W., Schneeweiss, A., Mueller, V., Woeckel, A., Lux, M.P., Hartkopf, A.D.,... Ettl, J. (2019). Update Breast Cancer 2019 Part 2-Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice. Geburtshilfe und Frauenheilkunde, 79(3), 268-280. https://dx.doi.org/10.1055/a-0842-6661
Banys-Paluchowski, M., Witzel, I., Aktas, B., Fasching, P., Hartkopf, A., Janni, W.,... Mueller, V. (2019). The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer. Scientific Reports, 9. https://dx.doi.org/10.1038/s41598-018-37259-2
Von Minckwitz, G., Huang, C.-S., Mano, M.S., Loibl, S., Mamounas, E.P., Untch, M.,... Geyer, C.E. (2019). Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer. New England Journal of Medicine, 380(7), 617-628. https://dx.doi.org/10.1056/NEJMoa1814017
Buckley, M.A., Woods, N.T., Tyrer, J.P., Mendoza-Fandino, G., Lawrenson, K., Hazelett, D.J.,... Freedman, M.L. (2019). Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus. Cancer Research, 79(3). https://dx.doi.org/10.1158/0008-5472.CAN-17-3864
Brunner, M., Schneider, I.H.F., Guenther, K., Grützmann, R., & Matzel, K. (2019). Permacol collagen paste for cryptoglandular and Crohn's anal fistula. Techniques in Coloproctology, 23(2), 135-141. https://dx.doi.org/10.1007/s10151-019-01932-z
Hadji, P., Stoetzer, O., Decker, T., Kurbacher, C.M., Marme, F., Schneeweiss, A.,... Tesch, H. (2019). The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial. Journal of Bone Oncology, 14. https://dx.doi.org/10.1016/j.jbo.2018.09.010
Arkadius, P., Marie, T., Fabienne, S., Thomas, W.P.F., Brigitte, R., Andreas, H.,... Tanja, F. (2019). Circulating tumor cells in metastatic breast cancer: clinical relevance and biological potential. Current Opinion in Obstetrics & Gynecology, 31(1), 76-81. https://dx.doi.org/10.1097/GCO.0000000000000514
Yang, Y., Wu, L., Shu, X., Lu, Y., Shu, X.-O., Cai, Q.,... Long, J. (2019). Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. Cancer Research, 79(3). https://dx.doi.org/10.1158/0008-5472.CAN-18-2726
Fasching, P., Schneeweiss, A., Kolberg, H.-C., Ettl, J., Fehm, T.N., Overkamp, F., & Lueftner, D. (2019). Translational highlights in breast cancer research and treatment: recent developments with clinical impact. Current Opinion in Obstetrics & Gynecology, 31(1), 67-75. https://dx.doi.org/10.1097/GCO.0000000000000510
Matthies, L.M., Taran, F.-A., Keilmann, L., Schneeweiss, A., Simoes, E., Hartkopf, A.D.,... Wallwiener, M. (2019). An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study. Journal of Medical Internet Research, 21(1), e10004-. https://dx.doi.org/10.2196/10004
Lux, M.P., Nabieva, N., Hartkopf, A.D., Huober, J., Volz, B., Taran, F.-A.,... Brucker, S.Y. (2019). Therapy landscape in patients with metastatic HER2-positive breast cancer: Data from the PRAEGNANT real-world breast cancer registry. Cancers, 11(1). https://dx.doi.org/10.3390/cancers11010010
Nabieva, N., Häberle, L., Brucker, S.Y., Janni, W., Volz, B., Löhberg, C.,... Fasching, P. (2019). Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients. International Journal of Cancer. https://dx.doi.org/10.1002/ijc.32294

Last updated on 2019-24-04 at 10:28